Supriya Lifescience Limited Cash Flow Reinvestment Rate
Supriya Lifescience Limited cash flow reinvestment rate. Supriya Lifescience Limited (SUPRIYA) has a Cash Flow Reinvestment Rate of 0.76x as of September 2025, reinvesting Rs422.49 Million (capex Rs422.49 Million ) from operating cash flow of Rs555.65 Million. Explore SUPRIYA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Supriya Lifescience Limited (2018–2025)
Cash flow reinvestment rate of Supriya Lifescience Limited from 2018 to 2025. Historical reinvestment intensity for Supriya Lifescience Limited across 8 annual periods. Explore reinvestment intensity of Supriya Lifescience Limited to see what proportion of operating cash flow is directed to capital expenditures.
Supriya Lifescience Limited Cash Flow Reinvestment Rate by Year (2018–2025)
Supriya Lifescience Limited cash flow reinvestment rate by year from 2018 to 2025. Year-by-year capital reinvestment analysis for Supriya Lifescience Limited. For the full cash flow conversion analysis, see how efficiently does Supriya Lifescience Limited generate cash.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.82x | Rs3.15 Billion | Rs1.73 Billion | Rs1.62 Billion | ▼ -35.3% |
| 2024 | 2.82x | Rs3.19 Billion | Rs1.13 Billion | Rs1.46 Billion | ▼ -22.8% |
| 2023 | 3.65x | Rs2.42 Billion | Rs661.87 Million | Rs1.08 Billion | ▲ +48.8% |
| 2022 | 2.45x | Rs1.20 Billion | Rs488.01 Million | Rs599.04 Million | ▲ +105.0% |
| 2021 | 1.20x | Rs956.51 Million | Rs799.30 Million | Rs482.41 Million | ▲ +183.2% |
| 2020 | 0.42x | Rs490.50 Million | Rs1.16 Billion | Rs245.25 Million | ▲ +193.3% |
| 2019 | 0.14x | Rs70.13 Million | Rs486.72 Million | Rs69.45 Million | ▼ -49.7% |
| 2018 | 0.29x | Rs49.98 Million | Rs174.52 Million | Rs49.30 Million | — |